Search Results - "Banham, Alison H."

Refine Results
  1. 1

    Therapeutic Antibodies against Intracellular Tumor Antigens by Trenevska, Iva, Li, Demin, Banham, Alison H

    Published in Frontiers in immunology (18-08-2017)
    “…Monoclonal antibodies are among the most clinically effective drugs used to treat cancer. However, their target repertoire is limited as there are relatively…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Notch signaling: its roles and therapeutic potential in hematological malignancies by Gu, Yisu, Masiero, Massimo, Banham, Alison H

    Published in Oncotarget (17-05-2016)
    “…Notch is a highly conserved signaling system that allows neighboring cells to communicate, thereby controlling their differentiation, proliferation and…”
    Get full text
    Journal Article
  4. 4

    The significance of FOXP1 in diffuse large B-cell lymphoma by Gascoyne, Duncan M., Banham, Alison H.

    Published in Leukemia & lymphoma (04-05-2017)
    “…Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of mature B-cell lymphoma. While the majority of patients are cured with immunochemotherapy…”
    Get full text
    Journal Article
  5. 5

    The notch ligand JAGGED1 as a target for anti-tumor therapy by Li, Demin, Masiero, Massimo, Banham, Alison H, Harris, Adrian L

    Published in Frontiers in oncology (01-01-2014)
    “…The Notch pathway is increasingly attracting attention as a source of therapeutic targets for cancer. Ligand-induced Notch signaling has been implicated in…”
    Get full text
    Journal Article
  6. 6

    Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse by BATES, Gaynor J, FOX, Stephen B, CHENG HAN, LEEK, Russell D, GARCIA, José F, HARRIS, Adrian L, BANHAM, Alison H

    Published in Journal of clinical oncology (01-12-2006)
    “…To assess the clinical significance of tumor-infiltrating FOXP3-positive regulatory T cells (TR) in breast cancer patients with long-term follow-up…”
    Get full text
    Journal Article
  7. 7
  8. 8

    ADGRL4/ELTD1 is a highly conserved angiogenesis-associated orphan adhesion GPCR that emerged with the first vertebrates and comprises 3 evolutionary variants by Favara, David M, Banham, Alison H, Harris, Adrian L

    Published in BMC evolutionary biology (12-07-2019)
    “…Our laboratory identified ADGRL4/ELTD1, an orphan GPCR belonging to the adhesion GPCR (aGPCR) family, as a novel regulator of angiogenesis and a potential…”
    Get full text
    Journal Article
  9. 9

    Elevated expression of the adhesion GPCR ADGRL4/ELTD1 promotes endothelial sprouting angiogenesis without activating canonical GPCR signalling by Favara, David M., Liebscher, Ines, Jazayeri, Ali, Nambiar, Madhulika, Sheldon, Helen, Banham, Alison H., Harris, Adrian L.

    Published in Scientific reports (23-04-2021)
    “…ADGRL4/ELTD1 is an orphan adhesion GPCR (aGPCR) expressed in endothelial cells that regulates tumour angiogenesis. The majority of aGPCRs are orphan receptors…”
    Get full text
    Journal Article
  10. 10

    Cancer/Testis Antigen PASD1 Silences the Circadian Clock by Michael, Alicia K., Harvey, Stacy L., Sammons, Patrick J., Anderson, Amanda P., Kopalle, Hema M., Banham, Alison H., Partch, Carrie L.

    Published in Molecular cell (04-06-2015)
    “…The circadian clock orchestrates global changes in transcriptional regulation on a daily basis via the bHLH-PAS transcription factor CLOCK:BMAL1. Pathways…”
    Get full text
    Journal Article
  11. 11

    ELTD1 Activation Induces an Endothelial-EMT Transition to a Myofibroblast Phenotype by Sheldon, Helen, Alexander, John, Bridges, Esther, Moreira, Lucia, Reilly, Svetlana, Ang, Koon Hwee, Wang, Dian, Lin, Salwa, Haider, Syed, Banham, Alison H, Harris, Adrian L

    “…ELTD1 is expressed in endothelial and vascular smooth muscle cells and has a role in angiogenesis. It has been classified as an adhesion GPCR, but as yet, no…”
    Get full text
    Journal Article
  12. 12

    Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A0201 by Trenevska, Iva, Anderson, Amanda P, Bentley, Carol, Hassanali, Tasneem, Wiblin, Sarah, Maguire, Shaun, Pezzella, Francesco, Banham, Alison H, Li, Demin

    Published in PloS one (09-04-2021)
    “…T-cell receptor mimic (TCRm) antibodies have expanded the repertoire of antigens targetable by monoclonal antibodies, to include peptides derived from…”
    Get full text
    Journal Article
  13. 13

    The Forkhead Transcription Factor FOXP2 Is Required for Regulation of p21WAF1/CIP1 in 143B Osteosarcoma Cell Growth Arrest by Gascoyne, Duncan M, Spearman, Hayley, Lyne, Linden, Puliyadi, Rathi, Perez-Alcantara, Marta, Coulton, Les, Fisher, Simon E, Croucher, Peter I, Banham, Alison H

    Published in PloS one (02-06-2015)
    “…Mutations of the forkhead transcription factor FOXP2 gene have been implicated in inherited speech-and-language disorders, and specific Foxp2 expression…”
    Get full text
    Journal Article
  14. 14
  15. 15

    A review of ELTD1, a pro-angiogenic adhesion GPCR by Favara, David M, Banham, Alison H, Harris, Adrian L

    Published in Biochemical Society transactions (01-12-2014)
    “…Epidermal growth factor, latrophilin and seven-transmembrane domain-containing 1 (ELTD1), an orphan G-protein-coupled receptor (GPCR) belonging to the adhesion…”
    Get more information
    Journal Article
  16. 16

    FOXP3+ regulatory T cells: Current controversies and future perspectives by Banham, AlisonH., Powrie, Fiona M., Suri‐Payer, Elisabeth

    Published in European Journal of Immunology (01-11-2006)
    “…Regulatory T cells (Treg) provide protection from autoimmune disease, graft‐versus‐host disease, transplant rejection and overwhelming tissue destruction…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19
  20. 20

    Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells by ALVARO, Tomas, LEJEUNE, Marylène, SALVADO, Ma Teresa, BOSCH, Ramon, GARCIA, Juan F, JAEN, Joaquin, BANHAM, Alison H, RONCADOR, Giovanna, MONTALBAN, Carlos, PIRIS, Miguel A

    Published in Clinical cancer research (15-02-2005)
    “…Purpose: Recent studies of Hodgkin's lymphoma (HL) have suggested that the presence of regulatory T cells in the reactive background may explain the inhibition…”
    Get full text
    Journal Article